Ryzodeg FlexTouch

Ryzodeg FlexTouch Caution For Usage

Manufacturer:

Novo Nordisk

Distributor:

DKSH
Full Prescribing Info
Caution For Usage
Special precautions for disposal and other handling: This medicinal product is for use by one person only. It must not be refilled.
Ryzodeg must not be used if the solution does not appear clear and colourless.
Ryzodeg which has been frozen must not be used.
A new needle must always be attached before each use. Needles must not be re-used. The patient should discard the needle after each injection.
In the event of blocked needles, patients must follow the instructions described in the instructions for use, see Patient Counselling Information.
Any waste material should be disposed of in accordance with local requirements.
The pre-filled pen (FlexTouch) is designed to be used with NovoFine/NovoTwist injection needles up to a length of 8 mm. It delivers 1-80 units in steps of 1 unit.
For detailed instructions for use, see Patient Counselling Information.
Incompatibilities: Substances added to Ryzodeg may cause degradation of insulin degludec and/or insulin aspart.
Ryzodeg must not be added to infusion fluids.
This medicinal product must not be mixed with any other product.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in